Cargando…

Forkhead Box R2 Knockdown Decreases Chemoresistance to Cisplatin via MYC Pathway in Bladder Cancer

BACKGROUND: Bladder cancer is a very common urological cancer globally, and cisplatin- or gemcitabine-based chemotherapy is essential for advanced bladder cancer patients. Many patients with bladder cancer have a relatively poor response to chemotherapy, leading to failure of clinical treatment. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yangle, Zu, Xiongbing, Hu, Xiheng, Wang, Long, He, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894368/
https://www.ncbi.nlm.nih.gov/pubmed/31761897
http://dx.doi.org/10.12659/MSM.917345

Ejemplares similares